Forskning ved Københavns Universitet - Københavns Universitet

Forside

Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

To evaluate the dose-response relationship of the recombinant glucagon-like peptide-1 (7-36) amide (rGLP-1) administered by continuous subcutaneous infusion (CSCI) in subjects with type 2 diabetes, with respect to reductions in fasting, postprandial and 11-h serum glucose profiles.
OriginalsprogEngelsk
TidsskriftDiabetes, Obesity and Metabolism
Vol/bind13
Udgave nummer7
Sider (fra-til)639-43
Antal sider5
ISSN1462-8902
DOI
StatusUdgivet - 2011

ID: 40246465